4//SEC Filing
Gelder Mark S. MD 4
Accession 0001415889-23-004865
CIK 0001130598other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:46 PM ET
Size
7.9 KB
Accession
0001415889-23-004865
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2023-03-13+20,667→ 20,667 total→ Common Stock (20,667 underlying) - Award
Stock Option (right to purchase)
2023-03-13+62,000→ 62,000 totalExercise: $0.73Exp: 2033-03-13→ Common Stock (62,000 underlying)
Footnotes (3)
- [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
- [F2]Each restricted stock unit is convertible into one share of common stock.
- [F3]These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001564390
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:46 PM ET
- Size
- 7.9 KB